P73, a p53-homologue gene, has been studied for its possible role in head and neck squamous epithelium (HNSE) dierentiation and carcinogenesis. P73 RNA and protein were analysed in 50 biopsies, including welland moderately-dierentiated carcinomas, and 21 matched normal adjacent tissues. P73 immunohistochemical analyses revealed intense p73 nuclear staining in basal and parabasal cells of normal squamous epithelium, in contrast with complete absence of staining in the more super®cial cell layers. Moderately-dierentiated carcinomas demonstrated homogeneous and diuse staining in all tumour cells, while only basal cells were stained in well-dierentiated carcinomas as in normal tissue. No correlation was observed between p73 and p53 protein expression. Immunostaining for p63, another p53-related protein previously described as being involved in HNSE morphogenesis and overexpressed in head and neck squamous cell carcinomas (HNSCC), was found to be similar to p73 labelling in carcinomas, but spread to the more dierentiated layers in normal epithelium. Biallelic expression of p73 was found in tumours as well as in matched normal tissues. Comparison of p73 transcript levels between tumours and normal tissues showed decreased mRNA expression in 5/17 (30%) tumours independently of the dierentiation status. Mutation and loss of heterozygosity analyses of the p73 gene revealed wild type status and no deletion. Our results strongly suggest that: (i) p73 is associated with homeostasis and control of dierentiation of head and neck squamous epithelium probably in concert with p53 and p63; (ii) down-regulation of p73 expression could participate in HNSE carcinogenesis. Oncogene (2001) 20, 5302 ± 5312.
Introduction
Tumour suppressor gene p53 is the most commonly altered gene observed in human cancers. P53 mutations are detected in more than 50% of many types of cancers (Harris and Hollstein, 1993; Levine, 1994; Soussi et al., 1994) , and in 69% of human head and neck squamous cell carcinomas (HNSCC) (Ahomadegbe et al., 1995) . Besides the well established role of genome guardian', p53 could also play a role in cell dierentiation, as previously shown (Woodworth et al., 1993; Brenner et al., 1993; Rotter et al., 1994) .
Recently, two p53 homologue genes have been described, i.e. p73 located at chromosome 1p36.33 (Kaghad et al., 1997) , and p63 mapped at chromosome 3q27 ± 29 . P63 has also been reported by other authors under the names p51, p40 and p73L (Osada et al., 1998; Trink et al., 1998; Senoo et al., 1998) . P73 and p63 share similar sequences with p53, notably in the regions corresponding to p53 central DNA binding and C-terminal oligomerization domains. In contrast with the unique p53 transcriptional protein, p73 and p63 genes encode several transcripts as a result of alternative splicing and the use of various promoters, generating isoforms with dierent N-and/or C-terminal domains which include the DNp73 and DNp63 proteins, lacking the Nterminal transactivation region (Kaghad et al., 1997; Yang et al., 1998 Yang et al., , 2000 De Laurenzi et al., 1998 , 1999 Casciano et al., 1999; Zaika et al., 1999) . Moreover, unlike p53 and p63, p73 is expressed by a single allele in some human tissues suggesting that p73 could be submitted to genomic imprinting (Kaghad et al., 1997; Mai et al., 1998) . Importantly, although p53 is frequently mutated in human cancers, p73 and p63 are not (Osada et al., 1998; Ichimiya et al., 1999; Han et al., 1999; Celli et al., 1999) .
Regarding biological activities, ectopic expression of full length isoforms of p73 and p63 can transactivate p53 target genes such as p21, Bax, Mdm2, Gadd 45, 14-3-3s, and induce growth arrest and/or apoptosis (Kaghad et al., 1997; Jost et al., 1997; Yang et al., 1998 Yang et al., , 2000 Zhu et al., 1998) . However, p73 and p63 appear to have biological activities distinct from those of p53, mainly founded on two lines of evidence. Firstly, unlike p53, p73 does not accumulate after UV radiation (Kaghad et al., 1997) , whereas DNp63 level decreases dramatically in normal keratinocytes or newborn epidermis in response to UV-B irradiation (Liefer et al., 2000) . Secondly, although Mdm2 binds both p53 and p73, only p53 is degraded by this interaction (Zeng et al., 1999; Dobbelstein et al., 1999) , whereas p53-inactivating viral oncoproteins, such as adenovirus E1B 55K, SV40 T antigen, and human papillomavirus E6, do not bind to p73 (Marin et al., 1998; Roth et al., 1998; Steegenga et al., 1999) .
P63 protein expression has been demonstrated in the basal cells of many human epithelial tissues and the major p63 variant in these basal cells is DNp63 Hall et al., 2000) . Mice lacking p63 present striking developmental defects indicating that p63 is essential for several aspects of ectodermal dierentiation maintenance during embryogenesis and morphogenesis Mills et al., 1999) . Recent studies concerning p73 have revealed that initiation from a promoter in intron 3 yields a major p73 protein product, DNp73, which, in contrast with full length p73 protein, failed to activate transcription from a p53-reporter gene, but retained DNA-binding activity . Yang et al. (2000) showed that nullizygous p73 mice exhibit profound neurological, pheromonal and in¯ammatory defects, but do not develop spontaneous tumours, in contrast with p53-de®cient mice. These results suggest roles for p73 in neurogenesis, sensory pathways and homeostatic control. Recent studies have also demonstrated the involvement of DNp73 in neurones development (Pozniak et al., 2000) . This isoform of p73 directly interacts with p53 to block its transcriptional activities and so inhibits neuronal apoptosis by acting as a direct antagonist to p53. So far, no study has been done to elucidate if p73 could modulate p53 activities involved in the control of proliferation and/ or dierentiation of human squamous epithelial cells. To answer this question, we investigated p73, p53 and p63 in HNSCC and matched normal head and neck squamous epithelium (HNSE). Our results strongly suggest that (i) p73 is associated with the homeostasis and control of dierentiation of squamous epithelial tissues in the oral cavity, and (ii) down-regulation of p73 gene expression could contribute to carcinogenesis of head and neck epithelium. The lack of correlation between p73 and p53 protein expressions also suggest that p73 cannot replace p53 when it is altered.
Results
As shown in Table 1 , tumour materials were obtained from 50 patients with HNSCC [hypopharynx (n=20), oral cavity (n=20), larynx (n=7) and oropharynx (n=3)] and compared to 24 matched normal tissues.
P73 protein expression in normal squamous epithelium and HNSCC
Immunohistochemistry was performed on 45 HNSCC (Table 1) , and 21 matched normal squamous epithelium samples, using an antibody directed against the p73 carboxy-terminal domain that recognizes the p73 major isoform, p73a. Nuclear p73a protein expression was found in all specimens analysed, in both normal squamous epithelium and carcinomas (Figures 1 and 2 ; see Materials and methods). The intensity and distribution of p73a labelling were independent of tissue location. In normal HNSE adjacent to the tumour (n=21), p73a staining was intense and homogeneous in all cells of the undierentiated basal layer and the ®rst suprabasal layers; no staining at all was observed in the super®cial dierentiated cell layers ( Figure 1a) .
Figure 1 P73, p53, p63 and p21 immunohistochemical analyses in normal HNSE. P73a protein (a) is expressed in the basal and parabasal cells (arrowheads), while no staining is observed in the more dierentiated cells. P53 protein expression (b) concerns a few cells of the basal layers. P63 staining is observed in basal and parabasal layers and in three or four adjacent more super®cial cell layers, corresponding to the spinous and granular layers (c). There is a complete absence of p21 labelling in the majority of normal HNSE (d) The intensity and pattern of proteins immunostaining were graded as follows, 7: unstained cell nuclei; +/7: less than 10% of stained cell nuclei and/or a variable number of cell nuclei faintly stained; +: between 10 and 50% of stained cell nuclei;
++: more than 50% of stained cell nuclei p73 status in head and neck tissues L Faridoni-Laurens et al Figure 2 P73, p53, p63 and p21 immunohistochemical analyses in HNSCC. In moderately-dierentiated carcinomas, p73, p53 and p63 staining is homogeneous, involving all of the tumour cells, as shown in serial sections (a,c) for p73 and p53, respectively, and in (e) for p63. In the well-dierentiated carcinomas, p73 immunoreactivity (b) is observed in the foci of undierentiated cells in the periphery of carcinomatous clusters (? 1), while foci of dierentiated cells, located in the centre of the clusters (U), do not show any labelling; some less dierentiated carcinomatous clusters show positive staining for all tumor cells (? 2). The pattern of p53 immunostaining (d) is dierent from that of p73, since it concerns most tumour cells, spreading to the most dierentiated layers (?), and suggests that this cancer harboured a p53 mutation leading to accumulation of p53 protein; U shows unstained cell nuclei in the centre of clusters. By contrast, the distribution of p63 labelling is identical to that of p73 (f); ?, stained cell nuclei at the periphery of the carcinomatous clusters; U, unstained cell nuclei in the centre of clusters. P21 protein expression is found in some of the foci of less dierentiated cells ((g,h), ? 1) and in the foci of more dierentiated cells (h, ? 2)
In moderately-dierentiated carcinomas (n=15), homogeneous p73 staining was observed in all tumour cells (Figure 2a ). In contrast, in well-dierentiated carcinomas (n=30), p73a expression was restricted to the undierentiated cell layer at the periphery of the carcinomatous clusters. The most dierentiated cells, localized in the centre of the clusters and adjacent to keratin pearls, did not reveal any p73a expression (Figure 2b ). Overall, our results strongly suggest that loss of p73a protein expression is associated with the level of dierentiation of squamous epithelial tissues of the head and neck.
Comparative p73, p63, p53 and p21 immunostaining in HNSCC and matched normal tissues P73 protein expression was compared to that of p63, p53 and p21 in 21 HNSCC matched to their 21 normal counterparts (HNSE).
Normal HNSE demonstrated immunostaining for p73a as well as for p53 and p63 (Figure 1a ± c and Table 1 ), indicating that all three proteins are expressed and are very probably involved in epithelial functions. However, a striking dierence in staining intensity and distribution was observed between these proteins: in comparison with p73 labelling, p53 labelling was restricted to a few cells of the basal layer and appeared to be less intense than that of p73; in contrast, p63 labelling was not only detected in the basal and parabasal cells, but also in the three or four adjacent more super®cial cell layers of the epithelium, corresponding to the spinous and granular layers. Intriguingly, complete absence of p21 staining was observed in 5/21 (24%) normal squamous epithelium specimens (Figure 1d ). In the other 16 cases (76%), p21 protein expression was very low and focal (data not shown).
In HNSCC, including 15 well-and six moderatelydierentiated carcinomas, p73a and p63 expressions were also consistently found, while p53 expression was observed in 12/21 cancers (57%) (Figure 2 ). In the 15 well-dierentiated carcinomas showing p73-and p63-positive staining, labelling was restricted to basal cells (Figure 2b and f) . In contrast, in the nine p53-positive well-dierentiated carcinomas, a higher percentage of cells were stained, involving the more dierentiated foci (Figure 2d) . A similar and homogeneous labelling involving all tumour cells was found in p73-, p53-, and p63-positive moderately-dierentiated carcinomas (Figure 2a,c,e) .
Eighteen of the 21 tumours (86%) showed p21 labelling, whose extent and distribution seemed to be independent of the level of dierentiation ( Figure  2g ,h). Strikingly, p21 protein expression was not associated with that of p73, p63 and p53 proteins, indicating that the in vivo induction of expression of the main downstream eector of the p53-family members is complex and must be elucidated. Figure 3 (a) Structure of the human p73 gene and PCR primers used to analyse p73 gene expression. P73 gene has 14 exons and encodes two major transcripts: full length p73a and p73b, which lacks exon 13. Primers p73-787F and p73-1045R were used to measure the level of all p73 transcripts from p73 (exons 6 ± 8 transcripts). Primers p73-1576F and p73-1833R were used to discriminate the transcript levels of each of the two isoforms, p73a and p73b. The sizes of cDNA fragments ampli®ed with each primer pair are shown in brackets. (b) Schematic diagram of the p73 gene indicating the location of the StyI (b1) and BanI (b2) p73 polymorphic sites in the p73 gene and the primers used for genomic PCR (p73-A1/p73-A2 (StyI) and p73-E5S/p73-E5AS (BanI)) and for RT ± PCR (p73-39F/p73-270R (StyI) and p73-525F/p73-654R (BanI)) p73 status in head and neck tissues L Faridoni-Laurens et al P73 transcript levels in HNSCC and matched normal tissues P73 encodes several protein isoforms generated by Nand C-terminus alternative splicing. To determine the level of expression corresponding to all p73 species, we therefore ampli®ed exons common to all mRNA isoforms by RT ± PCR (Figure 3a ). Conditions were set-up to yield quantities of RT ± PCR products according to a linear response, using GAPDH expression as internal control (Figure 4 ). Studies were performed on 17 HNSCC and 17 matched normal HNSE. P73 overexpression in HNSCC was arbitrarily de®ned as a twofold increase over normal HNSE expression, whereas p73 expression down-regulation was de®ned as a twofold decrease below normal HNSE expression. Interestingly, ®ve of 17 HNSCC (30%) showed a decrease of p73 transcript levels (ranging from two-to ®vefold), compared to the expression observed in the adjacent normal HNSE (Figure 4a , Hyp 5, Hyp 8, Hyp 11 and Hyp 16), whereas only one tumour (6%) presented overexpression of p73 mRNA (about 3.5-fold). In the remaining 11 pairs (64%), p73 transcript levels were similar in tumours and normal squamous epithelium.
P73 shows two major alternative splicing products at its C-terminal domain: p73b, which lacks exon 13, and full length p73a (Kaghad et al., 1997) . The signi®cant decrease of p73 expression in 5 HNSCC prompted us to investigate whether the stoichiometry between the Comparison of p73a and the alternatively spliced product p73b. A primer pair able to discriminate p73a expression from that of p73b was used. P73a is predominantly expressed in both normal and tumour tissues. Note that a decrease in global p73 expression (a) is associated with a similar decrease for the two major transcripts (Hyp 5, Hyp 8, Hyp 11, Hyp 16). (c) GAPDH was ampli®ed as a control Figure 5 Analysis of loss of heterozygosity (gDNA) and allelic expression (cDNA) of the p73 gene using StyI or BanI polymorphism. StyI polymorphism restrictions sizes are 543 bp (gDNA) and 232 bp (cDNA) for the (a) allele and 411 bp plus 132 bp (gDNA), and 180 bp plus 52 bp (cDNA) for the (b) allele; the 132 bp and 52 bp fragments are not shown. The sample A is a control for homozygous (b) allele. BanI polymorphism restriction sizes are 303 bp (gDNA) and 148 bp (cDNA) for the (a) allele and 160 bp plus 143 bp (gDNA) and 99 bp plus 49 bp (cDNA) for the (b) allele; the 49 bp fragment is not shown. No LOH was detected in HNSCC from heterozygous patients (Hyp 16, Hyp 5, OC 9). Biallelic expression was found in informative pairs of HNSCC and matched normal tissues. As a control of the biallelism consistently found, it is of note that Hyp 18 shows biallelic expression using both StyI and BanI polymorphism sites two p73 isoforms was modi®ed in these carcinomas. We designed primers located in exon 12 and exon 14 (Figure 3a ) in order to distinguish between these two transcripts. As shown in Figure 4b , we found that p73a was the predominant transcript and that the p73a/p73b ratio was similar in both carcinomas and matched normal tissues. The ®ve pairs (30%) showing a decrease of overall p73 transcript levels (exons 6 ± 8) in HNSCC demonstrated a simultaneous decrease of p73a and p73b transcript levels. A variation in the tumour p73a mRNA level is therefore associated with the same variation in p73b transcript levels (Figure 4b , Hyp 5, Hyp 8, Hyp 11 and Hyp 16), excluding an alteration of 3'-terminal domain splicing as a cause for decreased p73 expression.
Ten of 17 tumours of this study were welldierentiated carcinomas, while the other seven were moderately-dierentiated carcinomas. In contrast with the results reported by IHC for p73a protein, no correlation was found between dierentiation status and p73 transcript levels, probably due to tumour heterogeneity (Table 1) . Well-dierentiated carcinomas consist of clusters of cells composed of well-dierentiated cells and moderately-dierentiated cells, with less-dierentiated cells located in the periphery of the clusters; the extracted mRNA is therefore derived from a mixture of tissues. However, the decrease of p73 transcript levels in 5/17 carcinomas, regardless of the dierentiation status, suggests that a loss of p73 transcript expression could be associated with HNSE carcinogenesis.
Allelotyping and allelic expression analyses
In a preliminary study of lymphocytes from ®ve normal individuals and one neuroblastoma cell line, Kaghad et al. (1997) showed a p73 monoallelic expression, suggesting that p73 is submitted to genomic imprinting. The ®ve HNSCC with a reduced p73 mRNA level led us to the assumption that a deletion could eliminate the active expressed allele, while the retained p73 allele is imprinted and silenced. To test this hypothesis, we analysed p73 gene for LOH and allelic expression using StyI and/ or BanI restriction fragment length polymorphism (RFLP) (Figure 3b1,2) . Twenty-four HNSCC, including those analysed for p73 mRNA level, were studied and compared with their matched normal HNSE. Three individuals were found to be informative for StyI polymorphism and four for BanI polymorphism, while one individual was informative for both StyI and BanI polymorphisms ( Figure 5 and Table 1 ). None of these eight cases, including two of the ®ve HNSCC with reduced p73 transcript level, presented LOH for the p73 gene. An allelespeci®c study demonstrated p73 biallelic expression in eight HNSCC and eight matched normal HNSE ( Figure 5 and Table 1 ). Analysis of normal HNSE (n=2) and lymphocytes (n=5) from seven heterozygous patients for which tumour mRNA was not available also showed p73 biallelic expression in all seven cases (Table 1 , Hyp 9, Hyp 10 and data not shown).
These data de®nitively rule out monoallelism in normal HNSE and HNSCC. The decreased p73 expression in 5 HNSCC can therefore not be related to silencing of one p73 active allele.
Analysis of p73 and p53 gene mutations in hypopharyngeal carcinomas
Of 17 matched HNSCC/HNSE studied in molecular biology, eight were analysed for p73 and p53 mutations (Hyp 2, Hyp 3, Hyp 4, Hyp 5, Hyp 8, Hyp 11, Hyp 12 and Hyp 13).
Direct sequencing of exons 4 ± 10 of the p73 gene failed to show any mutation in these eight hypopharyngeal carcinomas. However, one sample harboured a polymorphism previously described in other tissues, at codon 204 (AAC ? AAT).
We also analysed these eight tumours for the presence of mutations in exons 1 ± 11 of the p53 gene and found the gene mutated in all eight carcinomas. Four samples carried missense mutations located at codon 173 (GTG ? ATG), codon 220 (TAT ? TCT), codon 272 (GTG ? ATG), and codon 280 (AGA ? GGA), while four other samples harboured deletions. In addition, p53 mutation was studied in 21 tumours (Ahomadegbe et al., 1995) . As expected, missense mutations seemed to parallel with nuclear p53 accumulation while deletions could be correlated with lack of nuclear protein accumulation (Table 1) .
Discussion
The HNSE, showing basal layers containing stem cells and progenitors to gradually dierentiated squamous cells, represents the paradigm of strati®ed epithelium which is consistently submitted to environmental genotoxic insults resulting from alcohol and tobacco consumption. In turn, this epithelium requires a perfect machinery to control and repair genotoxic damage and eliminate cells harbouring mutations. In this respect, p53 protein is likely to play a key role in the maintenance and control of HNSE homeostasis, in view of the highest frequency of alterations demonstrated to date in tumours, with 60% of mutations in HNSCC (Soussi et al., 1994; Ahomadegbe et al., 1995) . The two p53 homologues, p63 and p73, have been shown to elicit growth arrest and apoptotic properties, like p53. P63 and p73 could therefore also participate in HNSE homeostasis and could possibly replace p53 functions, when altered. The DNp63 isoform has been recently reported to be over-represented in HNSCC Yamaguchi, et al., 2000) , strongly suggesting that this gene acts as an oncogene in its Ntruncated version.
So far, no molecular and immunohistochemical studies have yet been conducted to specify the role of p73 in the biology and carcinogenesis of head and neck squamous epithelium. This study was dedicated to p73 status in head and neck tissues L Faridoni-Laurens et al answer this question by studying HNSE-HNSCC matched pairs, which were also analysed for p53 and p63 expressions.
P73 expression in HNSE basal cells. Is each p53 homologue an actor of HNSE differentiation?
Immunohistochemical analyses performed on normal tissues (oral cavity, oropharynx, hypopharynx and larynx) clearly showed that, in 21/21 HNSE (100%), p73 expression was restricted to undierentiated cells situated in the basal layers of strati®ed HNSE.
Immunostaining was uniformly distributed with a similar intensity in this cell compartment containing keratinocyte stem cells and progenitors, indicating protein expression in both proliferating and dormant cells. By contrast, dierentiated cell layers did not show any p73 expression. From this evidence, it is likely that p73 protein isoforms ± the nature of which remains to be determined ± are instrumental for the maintenance of HNSE stem cells and progenitors. Conversely, loss of p73 expression is associated with keratinocyte dierentiation. Comparative p53 and p63 immunohistochemical studies performed in serial HNSE sections demonstrated the speci®city of cell type staining, distinct from that of p73, as p53 was conspicuously expressed in a few basal layer cells whereas p63 staining occurred in 21/21 HNSE, uniformly throughout the basal, parabasal, spinous and granular cell layers.
P53 and homologue proteins appear therefore to be expressed sequentially throughout the HNSE dierentiation process. Based on our data, we propose that p73 probably plays a role in the maintenance of stem and progenitor cells, leading to the control of early epidermal dierentiation stages; by contrast, p63 should be involved in both early and later stages of dierentiation. The scarce and conspicuous p53 staining of a few basal cells suggests that p53 could be expressed during a very brief phase of the HNSE dierentiation control process, corresponding to a molecular step distinct from those involving p73 and p63. However, these latter data could also suggest that p53 would be induced or mutated, in those basal cells speci®cally injured by environmental aggressions, in these smoking and alcoholic patients. Mutated p53 cells could represent a very early step of squamous epithelium transformation resulting in malignancy, after selection and growth, as previously proposed in HNSE (Ahomadegbe et al., 1995) and sun-exposed skin, where p53 patches are also observed (Brash and Ponten, 1998) .
Noteworthy and strikingly, p21, which is considered to be the main eector of p53, when p53 plays the role of`guardian of the genome', and which has been demonstrated to be induced by ectopic expression of full length p63 and p73 cDNA (Kaghad et al., 1997; Jost et al., 1997; Yang et al., 1998 Yang et al., , 2000 Zhu et al., 1998) , was not at all expressed in the basal HNSE layers. This evidence suggests the existence of as yet unknown p53 eectors able to control dierentiation.
P73 and p63 immunostaining are restricted to undifferentiated HNSCC cells
P73a immunostaining in 45 HNSCC in various sites and presenting various histological types, including well-and moderately-dierentiated tumours, was found to speci®cally label undierentiated tumour cells with a similar intensity to that of matched normal HNSE tissue. Identical data were obtained with p63 immunostaining in 21 of the same HNSCC. Strongly positive p53 staining in 12 out of 21 HNSCC (57%), consistent with p53 mutations (Ahomadegbe et al., 1995) , was found in tumour cells regardless of moderately-(n=3) or well-dierentiated (n=9) histological types. Given these data, the modi®cation of p53 and p63 protein topography in HNSCC compared to HNSE suggests their involvement in HNSE carcinogenesis.
Down-regulation of p73 transcript levels, but no allelic alterations (LOH, imprinting) in HNSCC
Given that (i) antibodies recognizing p73 isoforms dierent from p73a isoform are not available for immunohistochemical studies, and (ii) immunohistochemistry is unable to quantify protein expression, we performed RT ± PCR, which permits us to distinguish and quantify p73 transcript species. Five of 17 HNSCC (30%) showed a signi®cant decrease of both a and b isotype mRNA, compared to HNSE, as con®rmed by the same mRNA transcript level decrease measured in the DNA binding domain. This decrease of transcript levels in HNSCC, independent of tumour dierentiation status, contrasts with the increase (Mai et al., 1998; Yokomizo et al., 1999) or lack of variation previously reported in various types of cancers. Moreover, lack of p73 expression due to allelic silencing by methylation of CpG islands of the p73 promoter region has been described in acute lymphoblastic leukemia and Burkitt's lymphoma. The mechanisms of regulation of p73 expression therefore appear to be tissue origin dependent.
The p73 gene locus, one of the most frequent sites of LOH in the genome, shows genomic imprinting as described in neuroblastoma lines (Kaghad et al., 1997) and con®rmed in normal lung tissue (Mai et al., 1998) . This evidence raised the possibility that loss of the transcriptionally active allele by a single event might be sucient to contribute to HNSE carcinogenesis. We found that biallelic expression was invariably found in HNSE and HNSCC, indicating that p73 is not submitted to genomic imprinting in these tissues. In this regard, in a recent survey of breast tissues, we found biallelic expression in normal breast epithelium and, by contrast and speci®cally in in¯ammatory breast cancers, the most aggressive form of breast carcinomas, silencing of one allele due to either LOH or imprinting (Ahomadegbe et al., 2000) . Variable results have been reported for p73 gene alterations in carcinomas derived from the various tissues composing the upper digestive tract, i.e., oral cavity, oropharynx, hypopharynx, larynx, oesophageal and gastric tissues. Our study clearly indicates a signi®cant decrease of p73 transcript levels in 30% of HNSCC with no associated LOH and consistent biallelic expression. By contrast, in oesophageal squamous cell carcinoma (ESCC), recurrent p73 alterations include LOH and overexpression, which is shown to be associated with LOI (Cai et al., 2000) . Similarly, LOI and elevated p73 expression are consistently found in gastric adenocarcinoma (Kang et al., 2000) . In both ESCC and gastric carcinoma, LOI and subsequent p73 overexpression are proposed to represent a partial compensatory mechanism for defective p53: physiological stresses such as hypoxia and nutrient deprivation would trigger p73 transcription, probably leading to apoptosis or growth inhibition of tumour cells. Dierences of p73 alterations pattern between HNSCC and oesophageal and gastric carcinomas may re¯ect a dierent physiological role played by p73 in these tissues.
In our series, the presence of p53 mutations in eight hypopharyngeal HNSCC, including three with p73 gene transcript level decrease, led us to investigate p73 gene mutations in HNSCC and matched HNSE; the lack of p73 gene mutation con®rmed previous studies performed on a larger number of various cancers (Kaghad et al., 1997; Kaelin, 1999) . Concomitant p53 mutations and p73 transcript level decrease in three HNSCC strongly suggest that dysfunction of both p53 and p73 are not exclusive, therefore supporting the concept of the speci®c functions played by each of these two genes. Whether or not accumulation of p53 and p73 alterations is associated with the degree of disease aggressiveness has yet to be elucidated. This is the ®rst study to investigate p73 in HNSCC tumour carcinogenesis. The morphogenic role of this gene during development and its likely physiological interaction with p53 and p63 in the process of squamous dierentiation, as re¯ected by the speci®c expression of these proteins in HNSE layers, suggest that p73 gene alterations may be involved in deregulation of HNSE homeostasis and dierentiation during carcinogenic events. Due to the presence of splice isotypes, in particular DNp73 with a dominant negative activity towards full length isotypes , we will now assess their representativeness in microdissected tissues from HNSE and HNSCC.
Materials and methods

Carcinomas and control specimens
The samples were collected at the Institut Gustave Roussy (Villejuif, France), from 1983 to 1999. All samples were obtained by surgery and were then quickly frozen in liquid nitrogen. Normal tissues adjacent to the tumours were also obtained with the patient's consent. Fifty HNSCC biopsies (hypopharynx (n=20), oral cavity (n=20), larynx (n=7) and oropharynx (n=3)) including 19 moderately-dierentiated and 31 well-dierentiated carcinomas, and 24 biopsies of matched normal epithelium adjacent to the tumour, were submitted to immunohistochemistry (IHC) and/or to molecular biology analysis (Table 1) .
Immunohistochemistry
Frozen HNSCC specimens and their matched normal HNSE were ®xed in AFA ®xative (5% acetic acid, 2% of 40% formalin, 75% ethanol and 18% distilled water) and paran embedded. Five mm thick sections were cut, dewaxed in xylene, and then dehydrated. After a short rinse in PBS, the sections were submitted to antigen retrieval treatment adapted to the antibody used. For p73 and p63, antigen retrieval was performed by pressure cooking in a pH 6 citrate buer; for p53 and p21, antigen retrieval was performed by microwave treatment for 365 min at 800 W in a pH 6 citrate buer and for 369 min at 800 W in a pH 7 citrate buer, respectively. After 20 min warming, endogenous peroxidase activity was blocked by 3% hydrogen peroxide in phosphatebuered saline (PBS) for 8 min. The sections were then covered with normal rabbit serum for p53 and p21, for 20 min, and then incubated with the primary antibody. The antibodies used were the polyclonal antibody raised against the p73a isoform (Sano®, Toulouse; 1 : 280 dilution), monoclonal antibody 4A4 for p63 (generous gift of Dr D Caput, Sano®, Toulouse; 1 : 750 dilution), monoclonal antibody DO7 for p53 (DAKO, Denmark; 1 : 280 dilution), and monoclonal antibody Ab-1 for p21 (Valbiotech, Paris; 1 : 50 dilution). The sections were then washed with PBS, and primary antibody binding was revealed using adapted systems: the very sensitive`envision polyclonal' (p73; DAKO, Denmark) or`monoclonal' (p63, p21; DAKO, Denmark), or the L-SAB system for p53 (DAKO, Denmark). After a 10 min incubation in DAB and washing with PBS, the slides were counterstained with hematoxylin and ®nally mounted. Positive and negative controls were used for each experiment. Examination of the whole section present on the slide allowed semiquantitative analysis of staining. Positive staining was assessed using an empirical algorithm taking into account intensity and percentage of stained cells (see Table 1 ).
RNA and DNA preparation
Frozen tissues were ground in liquid nitrogen and RNA and DNA were extracted by the guanidinium-thiocyanate CsCl gradient method.
Semiquantitative RT ± PCR assays cDNA was obtained by reverse-transcription (RT) of RNA (1 mg) using Superscript TM RNase H 7 (Gibco ± BRL kit) and random hexamers to prime the synthesis under conditions speci®ed by the manufacturer. One twentieth of the ®nal volume of the RT reaction mixture was subjected to polymerase chain reaction (PCR). In a preliminary study and for semi-quantitative analysis of p73 transcript levels, ampli®cation was performed by one cycle steps from 25 to 40 cycles and a kinetic ampli®cation curve was plotted, showing that a plateau phase was reached after 36 cycles; p73 transcript levels were therefore determined after 32 ampli®ca-tion cycles. Oligonucleotide primers (Figure 3a ) p73-787F (5'-TGGATGACCCTGTCACCGGC-3') and p73-1045R (5'-TGCTCCCGGTAGTGGTCCTCA-3'), were used for analysis of p73 transcript levels under the following conditions: 948C for 30 s, 658C for 1 min, and 728C for 2 min 30 s. A primer pair¯anking exon 13 was designed to measure the level of expression of p73a and p73b isoforms: p73-1576F (5'-CCGACCCCAGCCTCGTCAG-3') and p73-1833R (5'-p73 status in head and neck tissues L Faridoni-Laurens et al CTGAGCCGCCGATGGAGAT-3'), and was used for ampli®cation under the same conditions, for 32 cycles. Ampli®cation of GAPDH cDNA was used as internal control, using the GAPDH-513F (5'-CTGCACCACCAAC-TGCTTAG-3') and GAPDH-795R (5'-AGGTCCACCACT-GACACGTT-3') primer pair for 22 cycles. For each sample, 2 ml of ampli®ed p73 cDNA and 2 ml of GAPDH cDNA were mixed and electrophoresed on 6% polyacrylamide gels. As ampli®ed cDNA fragments were radiolabelled with [a 33 P]dATP, densitometric quanti®cation was performed after autoradiography using the Joyce ± Loebl chromoscan.
Allelotyping analysis of p73
StyI and BanI polymorphisms, located in exons 2 and 5, respectively, were used to determine p73 allele frequency and allele speci®c expression (Figure 3b1,2) .
To identify exon 2 polymorphism, PCR was performed on genomic DNA using intronic primers for exon 2: p73-A1 (5'-CACCTGCTCCAGGGATGC-3') and p73-A2 (5'-AAAAT-AGAAGCGTCAGTC-3'). Following a PCR procedure, consisting of 948C for 1 min, 588C for 1 min, and 728C for 2 min for 30 cycles, a speci®c 543 bp fragment was obtained. Two ml of the PCR product were then digested with StyI overnight. Heterozygous samples were chosen for RT ± PCR analysis to examine allelic expression. The p73-39F (5'-CGGGACGGACGCCGATG-3') and p73-270R (5'-GGTG-GAAGACGTCCATGCTGGA-3') primer pair was used for cDNA fragment ampli®cation under the following conditions: 948C for 30 s, 658C for 1 min, and 728C for 2 min 30 s for 34 cycles. Two ml of these PCR products were then digested with StyI overnight. The digested samples were analysed on 6% polyacrylamide gel.
For exon 5 polymorphism, intronic primers encompassing exon 5, p73-E5S (5'-CTGGACAGGGGTGCAGTTG-3') and p73-E5AS (5'-TGCTGTCCGGGATGCTG-3') were used to identify informative cases, followed by BanI digestion to detect this restriction fragment length polymorphism (RFLP). The PCR pro®le consisted in 948C for 1 min, 628C for 1 min, and 728C for 2 min for 27 cycles. The selected informative samples were examined for their allelic expression pattern by RT ± PCR and BanI digestion. RT ± PCR was performed with exonic primer pair (p73-525R (5'-TCAGCCACCTGGACG-TACTC-3') and p73-654F (5'-GTCACGTGCTCCGCTTTC-TT-3')) under the following conditions: 948C for 1 min, 608C for 1 min, and 728C for 2 min for 35 cycles.
To avoid the ampli®cation from contaminating genomic DNA, RT ± PCR primers for exons 2 and 5 polymorphism were speci®cally designed to span intronic sequences.
p73 and p53 gene sequencing
The entire coding regions of p73 and p53 genes were ampli®ed using p3 (5'-CCATCAGCTCCAGGCTCTC-3') and p4 (5'-CACCTTCGACACCATGTCG-3') primers for p73, and p5 (5'-GGTGGGAGGCTGTCAGTG-3') and p6 (5'-GGTGACACGCTTCCCTGG-3') primers for p53. The fragments generated were then sequenced with internal primers.
